{
    "code": "21000009",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=21000009",
    "time": "2021-10-01 03:34:02",
    "許可證字號": "衛署罕藥製字第000009號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/03\/15",
    "發證日期": "94\/03\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY02100000902",
    "中文品名": "威爾鋅膠囊50毫克",
    "英文品名": "WILIZIN CAPSULES 50MG",
    "適應症": "用於已接受過螫合劑治療的威爾森病患的維持療法。",
    "劑型": "130膠囊劑",
    "包裝": "12-1000粒塑膠瓶裝 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ZINC ACETATE DIHYDRATE",
    "限制項目": "01國　產",
    "申請商名稱": "6217082192  吉帝藥品股份有限公司",
    "申請商地址": "台中市北屯區綏遠路二段216之5號6樓",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049030005 營養與電解質液Nutrients and electrolytes",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200010550",
            "成分名稱": "ZINC ACETATE DIHYDRATE",
            "含量描述": "",
            "含量": "168.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "20200522134604717-109-05-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=21000009&Seq=003&Type=9"
        },
        {
            "title": "(加賦形劑）IT079A2 Wilizin 25.50mg1-104-11-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=21000009&Seq=002&Type=9"
        },
        {
            "title": "20200522134614750-109-05-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=21000009&Seq=001&Type=8"
        }
    ]
}